Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07128979) titled 'Efficacy and Safety Evaluation of Ruscus Aculeatus L in Patients With Hemorrhoids' on Aug. 7.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Double (Participant, Care Provider).
Primary Sponsor: Sultan Abdulhamid Han Training and Research Hospital, Istanbul, Turkey
Condition:
Hemorrhoid
Intervention:
Drug: Neoven 225 mg capsules
Recruitment Status: Recruiting
Phase: Phase 4
Date of First Enrollment: August 1, 2025
Target Sample Size: 250
Countries of Recruitment:
Turkey
To know more, visit https://clinicalt...